BAN2401 – Down’s syndrome with dementia / Traumatic brain injury

Down’s syndrome with dementia: the antibody BAN2401, which is now being clinically evaluated for the treatment of Alzheimer’s disease, can potentially also be used for other indications such as Down’s syndrome with dementia, as these patients develop dementia at around 40 years of age.

Traumatic brain injury (TBI): BioArctic has submitted a patent application for the antibodies BAN2401/BAN2401 back-up for the treatment of Traumatic Brain Injury. Some of these patients develop dementia after the injury.